Module 1: Psychopharmacology for Depression During Pregnancy and Postpartum

Amritha Bhat, MBBS, MD, MPH
Acting Assistant Professor, Psychiatry, School of Medicine, University of Washington, Seattle

OBJECTIVES FOR LEARNING OUTCOMES

At the conclusion of this activity, participants will be better able to:

  1. Describe risks of untreated depression and anxiety during pregnancy and postpartum for mothers and children.
  2. Discuss recent findings regarding risks of psychotropic medications during pregnancy and postpartum.
  3. Discuss how recent findings affect informed consent discussions with patients.

Presentation & Handout

Handout

Psychopharmacology for Depression During Pregnancy and Postpartum 


Video